EGF and cancer: The early in vitro studies on miR-31 suggest its role in acquisition of immortality in normal oral keratinocytes, thus progressing into malignant tumors in its early stage [28], or as a responder when oncogenic processes are initiated by other factors such as epidermal growth factor [30].